NKTR-255 at 1.5 µg/kg
18-255-01
Phase 3 small_molecule terminated
Quick answer
NKTR-255 at 1.5 µg/kg for Non-Hodgkin Lymphoma is a Phase 3 program (small_molecule) at NEKTAR THERAPEUTICS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEKTAR THERAPEUTICS
- Indication
- Non-Hodgkin Lymphoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated